This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988;37(3):301-55.

doi: 10.1016/0163-7258(88)90004-6.

Metabolism of oxazaphosphorines

N E Sladek¹

Affiliations

PMID: 3290910
DOI: 10.1016/0163-7258(88)90004-6

Review

Metabolism of oxazaphosphorines

N E Sladek. Pharmacol Ther. 1988.

. 1988;37(3):301-55.

doi: 10.1016/0163-7258(88)90004-6.

Author

N E Sladek¹

Affiliation

¹ Department of Pharmacology, University of Minnesota, Minneapolis 55455.

PMID: 3290910
DOI: 10.1016/0163-7258(88)90004-6

No abstract available

PubMed Disclaimer

Similar articles

Induction of DNA breakage in U937 cells by oxazaphosphorines.
Mazur L, Opydo-Chanek M, Stojak M, Baran J, Niemeyer U. Mazur L, et al. Folia Biol (Krakow). 2010;58(1-2):15-20. doi: 10.3409/fb58_1-2.15-20. Folia Biol (Krakow). 2010. PMID: 20420190
Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK, Waxman DJ. Chang TK, et al. Cancer Res. 1993 Jun 1;53(11):2490-7. Cancer Res. 1993. PMID: 8495410
Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
Marinello AJ, Gurtoo HL, Struck RF, Paul B. Marinello AJ, et al. Biochem Biophys Res Commun. 1978 Aug 29;83(4):1347-53. doi: 10.1016/0006-291x(78)91369-4. Biochem Biophys Res Commun. 1978. PMID: 697865 No abstract available.
Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.
Sládek NE. Sládek NE. Curr Pharm Des. 1999 Aug;5(8):607-25. Curr Pharm Des. 1999. PMID: 10469894 Review.
Metabolism and pharmacokinetics of oxazaphosphorines.
Boddy AV, Yule SM. Boddy AV, et al. Clin Pharmacokinet. 2000 Apr;38(4):291-304. doi: 10.2165/00003088-200038040-00001. Clin Pharmacokinet. 2000. PMID: 10803453 Review.

See all similar articles

Cited by

Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity.
Kurian R, Wang H. Kurian R, et al. Int J Mol Sci. 2025 Jan 24;26(3):988. doi: 10.3390/ijms26030988. Int J Mol Sci. 2025. PMID: 39940757 Free PMC article. Review.
Cytochrome P450-activated prodrugs.
Ortiz de Montellano PR. Ortiz de Montellano PR. Future Med Chem. 2013 Feb;5(2):213-28. doi: 10.4155/fmc.12.197. Future Med Chem. 2013. PMID: 23360144 Free PMC article. Review.
Clinical pharmacokinetics of cyclophosphamide.
Moore MJ. Moore MJ. Clin Pharmacokinet. 1991 Mar;20(3):194-208. doi: 10.2165/00003088-199120030-00002. Clin Pharmacokinet. 1991. PMID: 2025981 Review.
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells.
Reis-Mendes A, Carvalho F, Remião F, Sousa E, Bastos ML, Costa VM. Reis-Mendes A, et al. Biomolecules. 2019 Mar 11;9(3):98. doi: 10.3390/biom9030098. Biomolecules. 2019. PMID: 30862114 Free PMC article.
Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.
El-Serafi I, Abedi-Valugerdi M, Potácová Z, Afsharian P, Mattsson J, Moshfegh A, Hassan M. El-Serafi I, et al. PLoS One. 2014 Jan 22;9(1):e86619. doi: 10.1371/journal.pone.0086619. eCollection 2014. PLoS One. 2014. PMID: 24466173 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science